Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2805 of 5804
-
Can text messages help pregnant moms quit smoking? new study aims to find out
Disease control OngoingThe investigators propose to conduct a combined intervention that pairs SMS smoking cessation messages for patients with individualized training for OB clinicians to improve quit rates among pregnant smoking. The aim is to determine the effect of the intervention versus control o…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a One-Hour talk cut drinking in latino communities?
Disease control OngoingAlcohol use is a significant problem among Latinxs and immigration-related stress increases risk for substance use. A theoretically-based cultural adaptation of motivational interviewing (CAMI) that specifically integrated discussion of immigration-related stressors (e.g., stigma…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental cancer drug TNG908 tested in patients with rare gene deletion
Disease control TerminatedThis is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific MTAP-deleted tumor types. The study dr…
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug combo tested for tough cancers
Disease control OngoingThis is a first time in-human (FTIH) study designed to investigate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of remzistotug in participants with select loco-regionally recurrent solid tumors or metastatic solid tumors where curative or standard treatment…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to unlock cancer secrets in american indians
Knowledge-focused Recruiting nowThis clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast…
Phase: NA • Sponsor: New Mexico Cancer Research Alliance • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
BioNTech's RNA cancer therapy trial halted early
Disease control TerminatedThis study is an open-label, multicenter, Phase I/IIa, dose escalation, safety, and pharmacokinetics (PK) study of BNT142 followed by expansion cohorts in patients with Claudin 6 (CLDN6)-positive advanced tumors.
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Virtual genome center aims to close genetic care gap for newborns
Knowledge-focused OngoingThis study will provide rigorous evaluation of implementing a virtual genome center into community clinical settings without highly specialized resources, thereby offering generalizable insights as to how best to implement genomic medicine at scale and for other age groups. This …
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Can a computer help dementia patients remember and connect?
Symptom relief CompletedNon-pharmacological interventions and person-centered care strategies are important elements of care for people with Alzheimer's disease and related dementias. Life story work, which uses written and oral life histories to elicit conversation and memories, is an effective interve…
Phase: NA • Sponsor: Benjamin Rose Institute on Aging • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Keto diet battles plate method for diabetes control
Disease control CompletedThis study is being completed to compare two dietary approaches for participants with type 2 diabetes. This research will test whether a very low-carbohydrate or a plate-method diet better improves outcomes for blood glucose control and body composition for patients with type 2 d…
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can we predict who benefits from a heart device? new study aims to find out
Knowledge-focused OngoingCardiac resynchronization therapy with a defibrillator (CRT-D) in heart failure (HF) patients without left bundle branch block (non-LBBB) has been less beneficial to improve outcomes despite being a guideline indicated therapy, posing a significant treatment challenge. However, n…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Brain injury epilepsy study tests At-Home program to boost memory and ease caregiver burden
Symptom relief OngoingThe purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-PTE, to improve the quality of life and cognitive function in Service Members, Veterans and civilians with post traumatic epilepsy (PTE). This study will also assess the ability of the HO…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New hope for breast cancer survivors: trial tests vaginal treatments for hormone therapy side effects
Symptom relief OngoingIn this prospective active-controlled randomized trial the investigators will assess for the first time ever the different local treatments of vulvovaginal atrophy in breast cancer patients on endocrine therapy. These patients are currently inadequately treated based on ignorance…
Phase: PHASE4 • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Can a simple ultrasound predict immunotherapy success?
Diagnosis TerminatedPrimary objective is to assess whether changes in quantitative tumor perfusion parameters after 3 weeks of treatment, as measured by CEUS, can predict initial objective response to therapy, defined by current standard-of-care Secondary objectives are to evaluate if there is an o…
Phase: NA • Sponsor: Stanford University • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Nanoparticle inhaler could tame lung transplant rejection
Disease control CompletedPatients subjected to lung transplantation develop acute rejection or chronic rejection with an incidence of 45% after the first year. The major clinical phenotype of chronic rejection is bronchiolitis obliterans syndrome (BOS), which cause an establishment of chronic lung inflam…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Immune cell therapy takes on stubborn stomach bug in transplant patients
Disease control Recruiting nowThis is a Phase I dose-escalation study to evaluate the safety of norovirus -specific T-cell (NST) therapy for chronic norovirus infection in participants following hematopoietic stem cell transplantation (HSCT) or who are immunocompromised due to PID and have not undergone HSCT,…
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Vitamin a derivative paired with Low-Dose radiation shows promise for rare skin cancer
Disease control Recruiting nowThe researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF). Bexarotene is a form of vitamin A that activates proteins called retinoid X receptors, which may stop th…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Stool swap: could gut germs drive eating disorders?
Knowledge-focused Recruiting nowThe intestinal microbiota plays an essential role in digestion and, through the gut-brain axis, in the regulation of weight gain and eating behavior. The balaEating disorders (EDs) are serious pathologies affecting adolescence and young adults, likely to become chronic, with long…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New tech program aims to ease breastfeeding pain and keep moms going
Symptom relief CompletedEvery year, 1 million women cease breastfeeding (BF) before 6 months, the minimum time required for optimal maternal and infant health, development, and well-being. The highest rate of BF cessation occurs within 3 weeks after birth, with 30% of women ceasing BF due to acute breas…
Phase: NA • Sponsor: University of Connecticut • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Sound waves smash artery calcium in new leg treatment trial
Disease control CompletedProspective, multi-center, single-arm feasibility study to assess the safety and performance of the Shockwave Medical Mini S Peripheral IVL System for the treatment of heavily calcified, stenotic peripheral arteries.
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug SKB315 targets hard-to-treat tumors in early trial
Disease control Recruiting nowThis is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB315 for injection in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC